整理
|
內容
a defect in regeneration of HCO3 secondary to lack of adequate urinary NH4
=> most common: hypo-aldosteronism w/ hyperkalemia
=> pesistent hyperkalemia without obvious cause (eg, kidney failure, use of K supplements, or K-sparing diuretics)
hypo-aldosterone:
hypo-reninism w/ kidney dz, Or
a defect in RAA pathway
Normal or high aldosterone in hyper-K RTA => the defect is in response to aldosteone:
patients on ENaC blocker
Hyper-K impair NH4 excretion:
intracellular alkalosis (lumen K into PTC exchange for Na/H => inhibit ammoniagenesis
透過NKCC2抑制NH4在thick ascending limb of loop of Henle的reabsorption (K和NH4 compete for the same site on this transporter) => medullary NH4 absorption decrease
Hereditary hyperkalemia RTA vs. Acquired hyperkalemic RTA
Hereditary:
Decrease in aldosterone synthesis (congenital isolated hypoaldosteronism or pseudohypoaldosteronism type 2),
DCT NaCl absorption increase => 2nd hyperaldosteronism,
Resistance to aldosterone action => type 1 pseudohypoaldosteronism
Acquired:
secondary to hyporeninism: CKD due to DKD or CIN
Pirmary adrenal insufficiency can result from autoimmune adrenalitis, infectious adrenalitis (eg, HIV), and other disorders
Severely ill patients due to unknown mechanisms
Obstructive uropathy: impaired H and K secretion in CD (可能Urine pH > 5.5 when acidemia)
Drugs: K-sparing diuretics, antibiotics (TPM and pentamidine), NSAID, CNi, Angiotensin inhibitors, Heparin/LMWH (附圖)
Dx:
document low NH4 + K excretion: UAG + UOG
Urine pH < 5.5 (例外:obstr. uropathy, urine pH>5.5)
Low urien K excetion: TTKG + Urine K/Cre ratio
Drug screen
serum Aldosterone + renin: hypo-aldo +/- hypo-renin
Tx:
Short-term:
Normalize serum K => H+NH3 secretion增加改善metabolic acidosis + 增加PTC glutamine代謝,然後增加HCO3的產生
try to correct metabolic acidosis directly if failure to the 1st method
Long-term: Hyper-K in P’t w/ Hyper-K RTA
DC all drugs affecting K
Restrict dietary K
Control Hyperglycemia
Tx metabolic acidosis
Tx volume depletion
Use loop diuretics (排酸?)
Mineralocorticoids
Kayexalate
|
|
沒有留言:
張貼留言